GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Return-on-Tangible-Asset

Sphere Medical Holding (LSE:SPHR) Return-on-Tangible-Asset : -86.16% (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sphere Medical Holding's annualized Net Income for the quarter that ended in Dec. 2016 was £-4.94 Mil. Sphere Medical Holding's average total tangible assets for the quarter that ended in Dec. 2016 was £5.74 Mil. Therefore, Sphere Medical Holding's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2016 was -86.16%.

The historical rank and industry rank for Sphere Medical Holding's Return-on-Tangible-Asset or its related term are showing as below:

LSE:SPHR' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -929.58   Med: -80.46   Max: -61.22
Current: -61.22

During the past 9 years, Sphere Medical Holding's highest Return-on-Tangible-Asset was -61.22%. The lowest was -929.58%. And the median was -80.46%.

LSE:SPHR's Return-on-Tangible-Asset is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -2.69 vs LSE:SPHR: -61.22

Sphere Medical Holding Return-on-Tangible-Asset Historical Data

The historical data trend for Sphere Medical Holding's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Return-on-Tangible-Asset Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only -80.46 -61.80 -77.32 -73.49 -61.49

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -84.74 -79.05 -33.38 -45.19 -86.16

Competitive Comparison of Sphere Medical Holding's Return-on-Tangible-Asset

For the Medical Devices subindustry, Sphere Medical Holding's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Return-on-Tangible-Asset falls into.



Sphere Medical Holding Return-on-Tangible-Asset Calculation

Sphere Medical Holding's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2016 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=-4.513/( (10.642+4.038)/ 2 )
=-4.513/7.34
=-61.49 %

Sphere Medical Holding's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2016 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2016 )  (Q: Jun. 2016 )(Q: Dec. 2016 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2016 )  (Q: Jun. 2016 )(Q: Dec. 2016 )
=-4.942/( (7.434+4.038)/ 2 )
=-4.942/5.736
=-86.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2016) net income data.


Sphere Medical Holding  (LSE:SPHR) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Sphere Medical Holding Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.